XML 21 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Total revenue $ 16,400 $ 5,431 $ 37,257 $ 11,502
Revenue        
Total revenue 16,400 5,431 37,257 11,502
Operating expenses        
Cost of product revenue 1,428 0 3,011 0
Cost of product revenue - intangible asset amortization 259 0 776 0
Research and development 114,766 131,076 365,636 390,391
Selling, general and administrative 72,001 60,798 220,981 168,977
Total operating expenses 188,454 191,874 590,404 559,368
Loss from operations (172,054) (186,443) (553,147) (547,866)
Other income, net 10,150 13,136 29,744 9,728
Loss before income taxes (161,904) (173,307) (523,403) (538,138)
Income tax expense 0 254 0 254
Net loss (161,904) (173,561) (523,403) (538,392)
Unrealized gain (loss) on available-for-sale investments 106 (1) 2,175 (5,712)
Foreign currency translation adjustment 59 (9,485) (6) (9,485)
Comprehensive loss $ (161,739) $ (183,047) $ (521,234) $ (553,589)
Basic net loss per share (USD per share) $ (2.49) $ (3.09) $ (8.66) $ (9.66)
Diluted net loss per share (USD per share) $ (2.49) $ (3.09) $ (8.66) $ (9.66)
Weighted average common shares outstanding, basic (shares) 64,993,079 56,219,416 60,419,755 55,747,205
Weighted average common shares outstanding, diluted (shares) 64,993,079 56,219,416 60,419,755 55,747,205
Product Revenue        
Total revenue $ 16,400 $ 0 $ 36,056 $ 0
Revenue        
Total revenue 16,400 0 36,056 0
License and Collaboration Revenue        
Total revenue 0 5,431 1,201 11,502
Revenue        
Total revenue $ 0 $ 5,431 $ 1,201 $ 11,502